Cannabics Pharmaceuticals Inc. CEO talks with Uptick Newswire’s Stock Day Podcast About Cancer Research in the …

PHOENIX, Ariz., Nov. 06, 2018 (GLOBE NEWSWIRE) — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) (the “Company”) is a U.S public company that is developing a platform which leverages novel drug-screening tools and artificial intelligence to create cannabinoid-based therapies for cancer that are more precise to a patient’s profile. CEO Co-Founder, Eyal Barad, talked with Stock Day’s Everett Jolly.

“Cannabics Pharmaceuticals started about 5 years ago and today is mostly focused on the palliative and anti-tumor effects cannabinoids with cancer,” explained Barad. “We are truly focused on cancer, both the side effects and anti-tumor effects more at